A mother-of-four had her life turned upside down after doctors performed a c-section on her with tools which weren't sterile.

A Great Yarmouth mum was left using a wheelchair for nine years after a flesh-eating infection developed following a C-section.

A mum was unable to see her baby for three months after a flesh-eating bug infected her c-section scar - leaving her using a ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that data from the Phase 3 study of vilobelimab ...

InflaRx was founded in 2007 and maintains offices in Jena and Munich, Germany, and Ann Arbor, Michigan. In other recent news, InflaRx N.V. has disclosed post-hoc analyses indicating potential efficacy ...

ABSTRACT: Pyoderma Gangrenosum (PG) is an autoinflammatory condition mimicking Surgical Site Infection in the postoperative period and both these conditions differ entirely in terms of their ...

InflaRx ( (IFRX)) has shared an announcement. On December 30, 2025, InflaRx reported detailed Phase 3 data analyses for vilobelimab in pyoderma gangrenosum (PG), a rare, difficult-to-treat ulcerative ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed), ...